Dr. Carolyn Myers reports

FENDX SIGNS COLLABORATION RESEARCH AGREEMENT FOR MCMASTER FOR DEVELOPMENT OF CATHETER COATING USING ITS NANOTECHNOLOGY

Fendx Technologies Inc. has entered into a collaborative research agreement (CRA) dated Dec. 12, 2023, with McMaster University which details the research and development plan to create a protective catheter coating using the nanotechnology licensed pursuant to the licence agreement dated Feb. 5, 2021, as amended, between the company and McMaster.

Dr. Carolyn Myers, president and chief executive officer of Fendx, stated: "We are excited about the prospect of developing a coating for catheters using our nanotechnology which we believe will reduce catheter blockage caused by either blood clots or bacterial biofilms. Early work conducted at McMaster has demonstrated significant reduction in the adherence of both bacteria and blood which could potentially translate to reduced bacterial biofilm or blood clot formation. Our aim is to further this research to tackle the medical need to reduce catheter blockage rates, which can be costly and interfere with patient therapy. We anticipate the development of this coating formulation will also strengthen our overall intellectual property portfolio."

The CRA outlines more fully the research and development work to be conducted by McMaster on behalf of Fendx as well as a payment schedule for the maximum research financing requirements. The term of the CRA is for 24 months commencing on the effective date of Dec. 1, 2023, unless terminated in accordance with the provisions of the CRA. In the first and second year, maximum research financing to McMaster will be $150,547 each year.

About Fendx Technologies Inc.

Fendx is a Canada-based nanotechnology company focused on developing products to make people's lives safer by reducing the spread of pathogens. The company is developing both film and spray products to protect surfaces from contamination. The lead product under development, Repelwrap film, is a protective surface coating film that, due to its repelling properties, prevents the adhesion of pathogens and reduces their transmission on surfaces prone to contamination. The spray nanotechnology is a bifunctional spray coating being developed to reduce contamination on surfaces by repelling and killing pathogens. The company is conducting research and development activities using its nanotechnology in collaboration with industry-leading partners, including McMaster University. The company has an exclusive worldwide licence to its technology and intellectual property portfolio from McMaster, which encompass both film and spray coating nanotechnology formulations.

We seek Safe Harbor.